Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP650914.RATb0E-g9PZYXf_fLmUluD7q6ICJ8J7zn65uBgaZSQ3KE130_provenance.
• NP686683.RAuyXmG2D_P1oLaD4k7-D5YVX2pZ-gu8OFbHdTwafBK6s130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686683.RAuyXmG2D_P1oLaD4k7-D5YVX2pZ-gu8OFbHdTwafBK6s130_provenance.
• NP709539.RAkVKEP0jvL-IqPxMVtyEcK-IjmA7WVKa4QVLh8J2cT1Y130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP709539.RAkVKEP0jvL-IqPxMVtyEcK-IjmA7WVKa4QVLh8J2cT1Y130_provenance.
• NP158989.RA8roF9EU6-twKrv12L7ZuZTu_gQeHcXYRxh3jI3Vtn6Y130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP158989.RA8roF9EU6-twKrv12L7ZuZTu_gQeHcXYRxh3jI3Vtn6Y130_provenance.
• assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP301604.RA8R_XyhGXKhs3OapVY1z_cwJ821A4bnFjrQC_UKmvYRU130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301604.RA8R_XyhGXKhs3OapVY1z_cwJ821A4bnFjrQC_UKmvYRU130_provenance.
• NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP724473.RA0ATgZhu-Enhcv-ipGoIstHk4fgYGBFF_J4C4rQ-4Akw130_provenance.
• NP830668.RA8TC3-MzmWWmnwZCyqthjZQz0ExGUnluj7V63jSVPGXg130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP830668.RA8TC3-MzmWWmnwZCyqthjZQz0ExGUnluj7V63jSVPGXg130_provenance.
• NP265644.RAkYzlCZBazfqE5UgBqk2b2DNLZGl5M1tGvUL-WBvtBXQ130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265644.RAkYzlCZBazfqE5UgBqk2b2DNLZGl5M1tGvUL-WBvtBXQ130_provenance.
• NP1060743.RATN5OxpFvgvtZkxcMZme_rIyUZsPxahA4UYGdKf0IFiE130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060743.RATN5OxpFvgvtZkxcMZme_rIyUZsPxahA4UYGdKf0IFiE130_provenance.
• NP408017.RADOsK0XCwUUJdnkZSjDR1U7sNaGc5egJ12zYJYattpWc130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408017.RADOsK0XCwUUJdnkZSjDR1U7sNaGc5egJ12zYJYattpWc130_provenance.
• NP779815.RAIHF9emGxh3ZWu0tYbw15ZJdWLIgnU-k6Ydqkf_aP2-8130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP779815.RAIHF9emGxh3ZWu0tYbw15ZJdWLIgnU-k6Ydqkf_aP2-8130_provenance.
• NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408091.RAtY-vjBhPXuN_V1cD5_KXKs2_093qFSqpsrDqQ2M6oFo130_provenance.
• NP885133.RAM3MwuLMP382HdTmoPa_7VLlfmz_l52qPWIMNx1_WMnc130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885133.RAM3MwuLMP382HdTmoPa_7VLlfmz_l52qPWIMNx1_WMnc130_provenance.
• NP1060742.RAjEagOhANjfzDE6uHxJZtoxOgX0cFDmjFn1DnrgSvVAE130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060742.RAjEagOhANjfzDE6uHxJZtoxOgX0cFDmjFn1DnrgSvVAE130_provenance.
• NP265776.RA4zXpjkseNOha6_0dfarQ0u9byxIb0VMe5ttnrXc-mIY130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265776.RA4zXpjkseNOha6_0dfarQ0u9byxIb0VMe5ttnrXc-mIY130_provenance.
• NP407983.RA3B0K-u1cYklUbr803I8EPVLC98q5ndPk-ewSHJCdpEU130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407983.RA3B0K-u1cYklUbr803I8EPVLC98q5ndPk-ewSHJCdpEU130_provenance.
• NP265698.RAGKLHKQuBtOkJIH2ylcyBNFSagKvEyw6r61Riils_HRk130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP265698.RAGKLHKQuBtOkJIH2ylcyBNFSagKvEyw6r61Riils_HRk130_provenance.
• NP1060746.RAHY-xaoC7-UgidppuKowQCeGY05KM94Y8CfNmrZD2J1c130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060746.RAHY-xaoC7-UgidppuKowQCeGY05KM94Y8CfNmrZD2J1c130_provenance.
• NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_assertion description "[Activating mutations of class III receptor tyrosine kinases (RTK) FLT3, PDGFR and KIT are associated with multiple human neoplasms including hematologic malignancies, for example: systemic mast cell disorders (KIT), non-CML myeloproliferative neoplasms (PDGFR) and subsets of acute leukemias (FLT3 and KIT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1060745.RAy_bcRxGzWB9bGD0pLQeGgFPjMg9-fp29Mcm4FGiz42w130_provenance.